Table 5.
Incremental healthcare and workplace productivity costs in the Responsibility Deal scenario compared with the counterfactual scenario. costs in 2018 GBP
Disease | Healthcare costs in million (IQR) | Workplace productivity costs in million (IQR) | Total |
2011–2018 * | |||
CVD | £83 (£50 to £120) | £37 (£13 to £61) | |
Gastric cancer | £30 (-£6.4 to £66) | £8.4 (-£16 to £34) | |
Total 2011–2018 | £110 (£61 to £160) | £47 (£12 to £80) | £160 (£88 to 230) |
2019–2025 * | |||
CVD | £500 (£380 to £620) | £290 (£170 to £400) | |
Gastric cancer | £150 (£68 to £220) | £27 (-£8.0 to £61) | |
Total 2019–2025 | £650 (£450 to £840) | £320 (£162 to 460) | £970 (£760 to £1,200) |
Combined costs 2011–2025 * | |||
CVD | £583 (£430 to £740) | £327 (£183 to £461) | |
Gastric cancer | £180 (£61 to £286) | £35.4 (-£24 to £95) |
Negative values in the lower bound of the interquartile ranges are a consequence of stochastic noise in the model.
Numbers are rounded to the second significant digit.
*Years refer to the years in which the relevant policies were in operation, although outcomes can be accumulated up to 2035.
CVD, cardiovascular disease; IQR, interquartile range.